EQUIDACENT
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Oct 2021)
What this means for you
This application is over — abandoned 18 Oct 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88132059
- Mark type
- Stylized text
- Filed
- 26 Sept 2018
- Published for opposition
- 23 Jul 2019
- Abandoned
- 18 Oct 2021
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology
Owner
- CENTUS BIOTHERAPEUTICS LIMITED, CAMBRIDGE, GB
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 18 Oct 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Oct 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2021 — SOU EXTENSION 3 GRANTED
- 04 Mar 2021 — SOU EXTENSION 3 FILED
- 17 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2020 — SOU EXTENSION 2 GRANTED
- 07 Sept 2020 — SOU EXTENSION 2 FILED